Ep30: Orilissa and Lupron. Part 1 – Big Pharma’s Influence on Endo Information

Why are doctors so misinformed about endo treatment, and the benefits, risks, and limitations of GnRh drugs like Orilissa and Lupron? We talk about how drug companies are influencing both the doctor and the patient through marketing tactics, “awareness” campaigns, underwriting medical education credits for doctors, and more. We also talk about the lack of transparency around these tactics, how this misinformation affects our standard of care, and the quick facts around Orilissa and Lupron. Plus, Amy tells her story of being in a near menopausal state! CONNECT WITH US! INSTAGRAM: @in16yearsofendo WEBSITE AND RESOURCES: insixteenyears.com

Sources at: insixteenyears.com/lupron


Leave a Reply

Your email address will not be published.